Join
Live feed
·
INSIDERFilingvia Quantisnow
TherapeuticsMD Inc. logo

SEC Form 4: Donegan Michael C converted options into 115,000 shares and sold $15,947 worth of shares (29,790 units at $0.54), increasing direct ownership by 602% to 99,368 units (for tax liability)

ByQuantisnow·Wall Street's wire, on your screen.
TXMD· TherapeuticsMD Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TXMD (TherapeuticsMD Inc.) and more on Quantisnow.

SEC Form 4: Donegan Michael C converted options into 115,000 shares and sold $15,947 worth of shares (29,790 units at $0.54), increasing direct ownership by 602% to 99,368 units (for tax liability) | Quantisnow